USFDA conducts inspection at InvaGen manufacturing facility in Central Islip, NY, USA
InvaGen has received 5 inspectional observations in Form 483
InvaGen has received 5 inspectional observations in Form 483
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
The partnership is part of BioNTech’s strategy to develop novel prophylactic vaccines for the prevention of high-medical-need infectious diseases
Fillauer recently announced the launch of the first-ever bio-attributed prosthetic foot shell
The market capitalization of the company stood at Rs. 7,000 crore +
Apollo Telehealth has established more than 700 centers, in 7 states
Reinforces Henkel commitment to supporting customers and ecosystem in medical healthcare
Luran S MED 797S SPF30 is one of the first ASA materials in the market specifically for medical device housings
Subscribe To Our Newsletter & Stay Updated